Navigation Links
Stanford scientists find new solutions for the arsenic-poisoning crisis in Asia
Date:3/25/2009

Every day, more than 140 million people in southern Asia drink groundwater contaminated with arsenic. Thousands of people in Bangladesh, Cambodia, India, Myanmar and Vietnam die of cancer each year from chronic exposure to arsenic, according to the World Health Organization. Some health experts call it the biggest mass poisoning in history.

More than 15 years ago, scientists pinpointed the source of the contamination in the Himalaya Mountains, where sediments containing naturally occurring arsenic were carried downstream to heavily populated river basins below.

But one mystery remained: Instead of remaining chemically trapped in the river sediments, arsenic was somehow working its way into the groundwater more than 100 feet below the surface. Solving that mystery could have significant implications for policymakers trying to reverse the mass poisoning, said Stanford University soil scientist Scott Fendorf.

"How does the arsenic go from being in the sediment loads, in solids, into the drinking water?" said Fendorf, a professor of environmental Earth system science and a senior fellow at Stanford's Woods Institute for the Environment.

To find out, he launched a field study in Asia in 2004 with two Stanford colleagues: Chris Francis, an assistant professor of geological and environmental sciences, and Karen Seto, now at Yale University. The initial study was funded with a two-year Woods Institute Environmental Venture Projects grant. Five years later, the research team appears to have solved the arsenic mystery and is working with policymakers and government officials to prevent the health crisis from escalating.

"The real thing is, how do we help the people who are there?" Fendorf said. "But first, we have to understand the coupling of hydrology-the way the water is flowing-with the chemistry and biology."

Finding a study site

Arsenic-laden rocks in the Himalayas feed into four major river s
'/>"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Americans remain pessimistic about the environment, Stanford-AP survey finds
2. Stanford/Packard researchers find disease genes hidden in discarded data
3. Stanford researchers say climate change will significantly increase impending bird extinctions
4. Stanfords nanowire battery holds 10 times the charge of existing ones
5. Stanford researchers publish review of US medical device regulation
6. Stanford researchers make first direct observation of 3-D molecule folding in real time
7. Stanford researchers say living corals thousands of years old hold clues to past climate changes
8. Group led by Stanford physicist says theres an urgent need for nuclear detectives
9. Stanford researchers developing 3-D camera with 12,616 lenses
10. Clues to ancestral origin of placenta emerge in Stanford study
11. Inflammation triggers cell fusions that could protect neurons, Stanford research shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2014)... developed by researchers at the NIH,s National ... its collaborators to treat sickle cell disease ... business. The drug candidate, Aes-103, is the ... molecular mechanism of sickle cell disease. Baxter ... required for regulatory approval and commercialization. , ...
(Date:7/9/2014)... receptor antagonists can alleviate the symptoms of ... cognitive dysfunction and effectively scavenge amyloid beta ... (Aβ) vaccines reduced and eliminated Aβ deposition ... model, and significantly improved behavioral and cognitive ... First Affiliated Hospital of China Medical University, ...
(Date:7/9/2014)... inhabitants of the sea: tiny haptophytes of the type ... eye, when they are in bloom in spring, they ... on satellite images. "Together with other phytoplankton, Emiliania ... global photosynthesis output," states Prof. Dr. Georg Pohnert of ... the greenhouse gas carbon dioxide CO2 is ...
Breaking Biology News(10 mins):First drug candidate from NIH program acquired by biopharmaceutical company 2First drug candidate from NIH program acquired by biopharmaceutical company 3First drug candidate from NIH program acquired by biopharmaceutical company 4Short circuit in the food web 2
... tropical parasitic disease that can lead to life-threatening heart ... than previously thought, according to research from The University ... for four years now, and this year the number ... professor of integrative biology and philosophy at The University ...
... Cincinnati, OH, October 6, 2011 -- Directly advertising food ... providers, and the American Academy of Pediatrics and the ... impact of advertising on children,s healthy food choices. ... Journal of Pediatrics explores the relationship between ...
... can ever know about long-gone creatures is what they ... resurrect actual specimens and compare their features with their ... Toronto biologists helping to create a seed bank that ... allowing them to measure evolution caused by global change. ...
Cached Biology News:Chagas disease may be a threat in South Texas, says researcher 2Study suggests children's food choices are affected by direct advertising and parental influence 2Seed time-capsule will aid study of plant evolution amid environmental change 2
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... 14, 2014 iLab Solutions, the leader in ... new Director of Product Strategy. In this role, Michelle will ... sub-teams to guide in the development of iLab products. Her ... maximum possible benefit to the scientific community by offering the ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Calif., July 22 CV Therapeutics,Inc. (Nasdaq: CVTX ... results for 2008 after the market closes on Thursday, ... at 5:00 p.m. EDT,2:00 p.m. PDT, on the company,s ... on to the Company,s website at, http://www.cvt.com and ...
... is bringing aboard Ashton S. Maaraba, a key Pharmacy, Pharmacy Services ... , ... (PRWEB) July 22, 2008 -- PharmaSmart International ... Ashton S. Maaraba, a key Pharmacy, Pharmacy Services & HBC industry ...
... U.S. Department of Energy,s Lawrence Berkeley National Laboratory (Berkeley ... performed the first scanning tunneling spectroscopy of graphene flakes ... latest in a series of surprising insights into the ... carbon: an unexpected gap-like feature in the energy spectrum ...
Cached Biology Technology:CV Therapeutics to Announce 2008 Second Quarter Financial Results on Thursday, July 31, 2008 2Pharmasmart International Taps Top Executive Ashton Maaraba to Head Global Sales and Marketing 2A phonon floodgate in monolayer carbon 2A phonon floodgate in monolayer carbon 3A phonon floodgate in monolayer carbon 4A phonon floodgate in monolayer carbon 5